Guided Therapeutics Inc (QB) (GTHP) News

SMI was supposed to pay GTHP 100K when Chinese clinical trials were complete. SMI didn’t do that.
SMI was supposed to pay GTHP 100K as penalty when SMI couldn’t pay GTHP 100K. SMI didn’t do that either.
In spite of SMI is in full-payment default, company’s management continues to partner with them. When SMI wasn’t paying GTHP full payment, management’s job was to find a paying & trustworthy new partner. Company’s management has completely & miserably failed to do their job.

Till date, management hasn’t informed stockholders whether SMI paid them 200K$ or not? To give all this relevant & important information to stockholders was management’s job. Company’s management has completely & miserably failed to do their job.

Till date, management hasn’t informed stockholders whether SMI submitted to NMPA or not? & whether SMI paid 700K$ to GTHP or not? To give all this relevant & important information to stockholders was management’s job. Company’s management has completely & miserably failed to do their job.

The dividends are legally contracted dividends. The managers are entitled to those dividends.

Why do you say the Officers are "not doing their job?" I think they ARE doing their job. What specifically do you think they are not doing?

And how are the Officers "using stock as their personal piggy bank?" They aren't selling stock.

The Officers are personally and almost single-handedly funding the company during this down-time as we wait for the US clinicals to finish. They aren't borrowing from hedgies or toxic lenders, and their loans have warrants for 0.25 -- well above the current PPS. Because of the absence of toxic funding, the O/S and float are still exceptionally low: the O/S is still under 60 million and the float is under 25 million. I like that. You don't?

Regarding SMI: I don't think anyone ever believed that SMI would accomplish anything. They DID accomplish something, to my surprise: they completed a 400-patient clinical trial in China run by noted physicians, and that trial had better-than-expected results. That's a win for Guided, even though SMI will likely never submit anything to the NMPA. You are correct that SMI hasn't made their scheduled payments to Guided, but I never expected them to. You did, apparently? Honestly?

I believe that a different entity can submit the application to the NMPA. You don't believe that? It would require negotiations and new agreements, most likely involving Shenghuo, but I don't see that as a negative for Guided.

Try to answer without your usual hyperbole -- give concrete responses to defend your assertions. Thanks in advance.

When company's management use stock as their personal piggy bank, stockholders suffer losses.
When company's management reward themselves dividend stock for not doing their job & doing nothing to add stockholders’ value , stockholders suffer losses.

You admitted that you're buying while you're bashing.

Why don't you stop buying for a month and let someone else get some shares under .10?

And when are you going to learn how to read a 10-Q?

Till yesterday the bid was at 0.101$ & today the bid is at 0.093$
Something very bad is happening & stockholders have no information about it.
Either SMI is not filing to NMPA
Or
SMI is not paying anything to GTHP
Or
There are issues in US clinical trials
Or
All of the above!
🤦

July 10th GTHP published a PR stating that SMI will file to NMPA in next 4-6 weeks. That deadline is passed. When & “IF” SMI files for NMPA, at that time SMI was supposed to pay GTHP approximately 700K$.
Did SMI file for NMPA?
Did SMI pay GTHP 700K$?
Did SMI pay GTHP 200K$ in penalty?
When will GTHP stockholders know answers to these questions?

Here we go again. It’s deja vu all over again. As soon as a slight uptick in bid & that’s immediately taken.

A technologically advanced & great product, a company having great potential to handsomely reward stockholders is completely ruined by incompetence, ineptitude & laziness.

Those who are incompetent, inept, lazy & professional swindles/con-artists they exhibit unethical behaviour of continuing with a full payment defaulted & non-trustworthy partner.

It’s because of incompetence, ineptitude, laziness & outright fraudulent nature / behaviour of management, stockholders always suffer & bare losses.

Here you go! Sell sell & nothing but sell. Absolutely no buying support.

And the saga Déjà vu continues.
Bid is not at all going up. It’s stubbornly sitting at 10 cents, whereas ask keeps on precipitously going down & down & more down

Somebody selling $550 worth of stock does not constitute a seller. Further, if they were selling on this "insider info" that you claim only to make enough to buy a ham sandwich than they are a bigger moron than you.

You promised the price would fall to 6 cents. When is your promise going to come true?

We know you are bashing to get the price lower because we know you are buying. You're doing a crappy job, though, because the PPS is holding above a dime even though there's no news. Can you please do a better job of bashing?

Something extremely bad is happening. 1 of the following could be happening or some of the following could be happening or all of the following could be happening
SMI is not paying a dime to GTHP
SMI is again delaying filing to NMPA
Issues discovered in US trial

The fact that sellers are selling at 0.11$ is a clear indication that the seller/s know something bad that no one knows.

And the saga Déjà vu continues
If at all this stock is traded then it’s just sells sells & more sells & nothing else. Neither any buys nor any buying support.
The bid stubbornly sits at one place & doesn’t move up at all. If at all the bid slightly moves up then it’s immediately taken & selling resumes.
Very very sad & unfortunate state of affairs for this stock.
The reason is technologically great product in wrong hands.
The reason is not publishing the most relevant & important material information. Whether that’s being done intentionally or purposefully or deliberately is anyone’s guess.

raise your bid to .15 and it will fill.

3rd consecutive day & not a single GTHP stock is traded. GTHP management congratulations for making this an illiquid stock. Whether GTHP management is purposely & deliberately not publishing the most important & relevant information about SMI’s payment to GTHP, is really anyone’s guess. But that’s the reason why GTHP is now an illiquid stock.

If you carefully look at GTHP’s trading yesterday, you will notice that broker-dealer/market-maker GTSM tried to manipulate the stock price. When other broker-dealers/market-makers noticed it, they intervened & manipulation appears to have stopped. Broker-dealers/market-makers are able to manipulate the stock price only because GTHP management is not releasing material important & relevant information. They should release immediately :

1) Did SMI pay 200K$ penalty to GTHP by either May-end ‘24 or June-end ‘24? Or are they on track to pay it by July-end ‘24?
2) At the time of filing to NMPA, SMI was supposed to pay 700K$+ to GTHP. “If” SMI is really going to file to NMPA in next 4-5 weeks, then is SMI on track to pay 700K+$ to GTHP at the time of filing?

Are you still hopeful?

Take a look at today’s complete BS PR that doesn’t talk about the most important & relevant things for stockholders:

1) Did SMI pay 200K$ penalty to GTHP by either May-end ‘24 or June-end ‘24? Or are they on track to pay by July-end ‘24?
2) SMI was supposed to file to NMPA , 1st by 1-Q end ‘24 that deadline they missed & then 2nd by 2-Q end ‘24 that deadline they missed as well & now the filing is delayed by another four to five weeks. This is nothing but kicking the can down the road. From this anyone can guess the real intentions of SMI, “if” they are really going to file to NMPA or not?
At the time of filing to NMPA, SMI was supposed to pay 700K$+ to GTHP. Why today’s completely BS PR don’t mention anything about it?

Market don’t care about what bunch of Chinese doctors say about Chinese clinical trial data. Market cares about whether SMI is paying to GTHP or not? Why GTHP management hides this most important & relevant information from stockholders?

If you are delusional then you will believe that SMI at the time of filing will pay 700K+$ to GTHP.

Why don't you and your cabal stop buying for a few weeks?

Let the PPS drop to .06. Then you could have a field day bashing. You'd still have plenty of time to buy before the US clinicals finish.

That was you and your cabal buying yesterday. I could tell it was you by the way you kept inching up the bid by .0001

How many did you get? 50,000 ?

Are you still hopeful?

Let’s hope thank you so much!

Hate to pop your hope bubble, but at the end of June’24, SMI is “supposed” to file for NMPA approval & pay GTHP approximately 700+K$. If & it’s a very big if, SMI files for NMPA approval, the zillion $ question is, do they have funds to pay 700+K$ to GTHP. Till date, they haven’t paid GTHP the full amount & in spite of their partial default, GTHP’s management continues to partner with them. That’s why stock is at an absolute miserable situation. The most important thing in any OTC penny stock is what the bid’s at & not what the ask’s at. Unless bid significantly increases, this stock has no future.

Something cooking glad I added more few days ago when we had a lot of volume$$$ load and hold the key here$$$ should be above 1$ soon good luck y’all

He's buying. See posts 15611 and 15615 where he lets it slip that he's buying.

Not the brightest bulb on the tree.

Let him bash. In the long run it won't hurt us at all.

Kinda fun to poke him with a stick though, I have to admit.

I’m telling you this again. Don’t bother replying my posts, intelligent people understand if told once but for unintelligent people like you same thing needed to be told again-&-again. Do you finally get it? Don’t bother replying my posts.
You once said “this is the place where intelligent insight is supposed to meet with others that have something relevant to say about investment in GTHP”.
So if you have anything intelligent to say or anything relevant to say about investing in GTHP, then say it otherwise don’t bother replying to my posts.

So now that you have concluded that the stock has no future can you do us all a favour and go find another sandbox to play in?????

This stock has no future & is in the worst situation. The moment it tries to go up even slightly heavy selling pressure brings it down. There’s no buying support for this stock nor any buyers for this stock. There are only sellers. The management knows that their Chinese partner neither can be trusted nor it’s paying GTHP full due money. In spite of a default the management continues to partner with them and that’s the reason for stock’s price decline.

I told you once not to bother replying my posts but unintelligent people like you need to be told twice. So I’m telling this to you twice now. Don’t bother replying my posts. Do you finally get it? Don’t reply my posts. Period.

You think 2themoon1 is "meddling in other people's threads?" new flash, this IS 2themoon1's thread.

Try to follow this chronology:

the start of the thread: #15619 by 2themoon1
#15620, my reply to 2themoon1
#15621, moneydreamer also replies to 2themoon1
#15627, Pacjd butts in with something ignorant about deferred revenue to further his campaign to smear the Directors he hates
#15628, I explain to Pacjd how Deferred Revenue works and why his post is not only off topic but pretty much 100% wrong
#15629, myjog butts in with an attempt to hijack the thread by trying to divert attention to HIS agenda of bashing
#15630, I ask myjog and Pac2jd to stop trying to hijack threads
#15631, myjog embarrasses himself further
#15632, my direct response to myjog
#15633, myjog persists, even though he's still not actually saying anything
#15634 and #15635, direct replies to myjog's post
#15636, myjog calls 2themoon1 an "idiot" because he thinks 2themoon1 "meddles in other's people's threads" -- even though 2themoon1 STARTED THIS THREAD

That's pretty funny.

I think it's time to give myjog a rest and bring back your other alias myjo.

i was referenced in the back and forth "thread" today so a response was merely low hanging fruit. ..which you leave out there constantly. Just as a reminder this is a place where intelligent insight is supposed to meet with others that have something relevant to say about investment in GTHP....you provide none of that and therefore are just a big ball of THREAD. go elsewhere where you're verbal diarrhoea might be welcome.

Idiots like you meddle into other people’s threads. 1st learn to stay away from threads where you are not mentioned & don’t bother to reply to my posts.

you can prove only that he/she knows and takes the time to read filings by the company, that SURPRISE actually has meaningful material that a real investor would look for. You on the other hand, are just a huge YAWN. you bring nothing intelligent or insightful at all. spend more time trying to be a better human and leave the investing stuff to those that understand it.

Go ahead, "prove" something about me.

Talk is cheap.

I can also prove many things about you.
So stop trying to hijack my threads with your agenda.

Name ONE "lie" that I "spread" about you.

I can prove that you used two aliases to create a fake conversation.

I can prove that you admitted to buying while you were bashing.

I can prove that you said the CEO stole money from the company.

I can prove that you said the Directors were fake.

And "rumors?" I don't spread rumors.

When I reply to one of your posts, notice that I am directly addressing something you specifically said. If you want to stay on topic and address something I specifically said, feel free. I'm merely asking you to stop trying to hijack my threads with your agenda.

Same here, stay out of my threads so that I won’t embarrass you further.
When you will stop spreading lies & rumors about me, I’ll stop telling truth about you.

That's not what I said, and that's not what I'm talking about. I was having a discussion with 2themoon1 because, unlike you and the guy who's suing Shenghuo, 2themoon1 knows how to read a balance sheet and an SEC filing.

If you two bashers kindly stay out of my threads, I won't embarrass you further.

Penalty money from SMI?
When they couldn’t pay 100K by March-end ‘24. What makes you think that they will be able to pay 200K by May-end ‘24?
Also the 700+K money will be paid by SMI, “if” they file by June-end ‘24. No stockholders believe that SMI can pay that either.

you mean "when and if BOOKED as revenue." Deferred Revenue is already collected.

And it only has to be shared with K2 if it came from SMI. $747,780 didn't all come from SMI so $747,780 does NOT have to be split with K2.

And the SMI payments are not split 50/50; the 8-K I shared explains how SMI money is dispersed.

And the penalty money from SMI doesn't have to be shared with K2. That would not be booked as deferred revenue.

Deferred revenue balance of $747,780, when and if collected has to be shared with Shenghou, LLC now know as K2.

There’s absolutely no good news in this for anyone. It’s neither a good news for me nor a good news for any stockholders.
It’s high time for this company’s directors to have a conference with stakeholders. Under their leadership stock lost more than 60% of value. Stockholders deserve an explanation as to what exactly they will do to bring value to stockholders.

that's good news for you, since you admitted that you are buying.

Next stop 0.0656 &
then 0.065 &
then 0.0558 &
then 0.0328

No future for this stock.

Where in latest 10-Q it says that GTHP will co-sign SMI’s loan?

The float here is remarkably low. Can't deny that.

I've been messing with pinkie stinkies with billions in the A/S and O/S. Hard to believe how reckless people can be with their money. When the OTC gamblers find GTHP it could exponentially skyrocket.

And they will find it. Maybe not until 2025 but they WILL find it.

The company is going to need money though, assuming that SMI continues their pattern of promising money and not paying it. You all know that I don't believe SMI has the money, but they DID complete the clinical trials.

Anyone who bothers to read the SEC filings knows that the warrants are priced pretty high. That's a good thing in a way, but I'd rather the company get funding through the insiders exercising those warrants instead of borrowing.

I'm not clear on how the "we will borrow money on SMI's behalf" scenario will work. Sounds like Guided is cosigning a loan, and SMI is a poor credit risk.

2024 is going to see some PPS dips because the clinical trials aren't going to finish before the end of the year, and investors get restless when they see other stocks popping. I am convinced that the insiders who own a lot of stock are holding. It's not the insiders who have been occasionally selling larger lots (large for this stock, anyway) because the Form 4's show that they have not been selling. The insiders know more about what's going on than I do, so if they are holding, so am I.

Our resident basher has disappeared after he accidentally let it slip that he is actually buying. I expect him to reappear with a new alias, or maybe he'll go back to his other alias (just add the letter g to the end of his current alias).

100% Agree been holding here for years

The fourth clinical site just got approval on March 28 to start the trials. Hopefully that fourth site will speed things up.

They reported the SMI money as Deferred Revenue.

Operating expenses reduced significantly in Q1.

But it's going to be a slow journey for the rest of 2024. I expect some weak hands to lose patience and sell.

10-Q today....foolish sellers in my opinion

In the United States, the Company is actively pursuing FDA approval by initiating a clinical trial protocol involving approximately 400 study participants, with the exact number depending in part on the numbers of women in the study both with and without cervical disease. The protocol was drafted with input from FDA and at least two prestigious clinical centers that are participating in the study.
Clinical study monitoring visits are required by FDA to ensure that the study is being conducted under FDA guidelines and in compliance with the study protocol. Findings from the initial clinical study monitoring visits include:


1)
There have not been any adverse events reported related to the use of LuViva.




2)
All three monitored clinical study sites are adhering to the study protocol and are completing the necessary case report forms according to FDA standards.




3)
Enrollment rates have increased during 2024.




4)
Approximately 122 patients have been enrolled and tested.

Based on current and expected enrollment rates, we expect the study to be completed in 2024, however there can be no assurance that the study will progress within the expected timeline.

Leave out the hyperbole and show me a specific example of where I lied.

Cite the post number and quote the words.

You can't.

So you need to stop calling me a liar. You can post reasons why you are "bearish" (LOL even though you admit to being a buyer) and you can offer arguments that counter my arguments, but you can't call anyone a liar without citing proof -- that is libel.